4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-014601
Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Eastling Thomas Wilson · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-16 | Exercise or conversion : show line 1 in the form | +15,000 | $6.93 | $103,950 | 15,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-16 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −15,000 | 299,652 | D |
Loading xslF345X05/form4.xml…